Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Investigation of chalcogen bioisosteric replacement in a series of heterocyclic inhibitors of tryptophan 2,3-dioxygenase.

Journal article

Kozlova A. et al, (2021), European journal of medicinal chemistry, 227

Rational Design of Original Fused-Cycle Selective Inhibitors of Tryptophan 2,3-Dioxygenase.

Journal article

Kozlova A. et al, (2021), Journal of medicinal chemistry, 64, 10967 - 10980

Arid5a: A Missing Link between EMT and Tumoral Immune Resistance

Journal article

Van den Eynde BJ., (2021), Cancer Immunology Research

Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase

Journal article

Klaessens S. et al, (2021), Proceedings of the National Academy of Sciences, 118, e2022447118 - e2022447118

IDO1 and TDO inhibitory evaluation of analogues of the marine pyrroloiminoquinone alkaloids: Wakayin and Tsitsikammamines.

Journal article

Levy T. et al, (2021), Bioorganic & medicinal chemistry letters, 40

TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism

Journal article

Canè S. et al, (2021), Journal for ImmunoTherapy of Cancer, 9, e001798 - e001798

Efficiency of the four proteasome subtypes to degrade ubiquitinated or oxidized proteins

Journal article

Abi Habib J. et al, (2020), Scientific Reports, 10

NO• /RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer.

Journal article

Wang L. et al, (2020), International journal of cancer, 146, 3160 - 3169

Preclinical murine tumor models: a structural and functional perspective

Journal article

Guerin MV. et al, (2020), eLife, 9

Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors

Journal article

Schramme F. et al, (2020), Cancer Immunology Research, 8, 32 - 45

Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?


Van den Eynde BJ. et al, (2020), ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4, 4, 241 - 256

Production of spliced peptides by the proteasome

Journal article

Vigneron N. et al, (2019), Molecular Immunology, 113, 93 - 102

Influenza A Virus Infection Induces Viral and Cellular Defective Ribosomal Products Encoded by Alternative Reading Frames

Journal article

Zanker DJ. et al, (2019), The Journal of Immunology, 202, 3370 - 3380

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism

Journal article

Zhu J. et al, (2019), Cancer Immunology, Immunotherapy, 68, 835 - 847

Load More